EYPT:NASDAQ
EyePoint Inc
၃.၄၀ US$
arrow_downward
-၁.၇၃%(-၀.၀၆၀) 1D
၃.၄၅ US$
arrow_upward
+၁.၄၇% (+၀.၀၅၀)bedtimeAfter hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
၃.၄၄ US$
High
၃.၅၇ US$
Low
၃.၃၈ US$
Mkt. cap
၂၉.၃၁ ကုဋေ
Avg. vol.
၃.၅၂ သန်း
Volume
၁.၉၄ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၃.၀၅ US$
EPS
-၃.၇၄ US$
Beta
၁.၆၇
Shares outstanding
၈.၆၂ ကုဋေ
No. of employees
၂၁၄
Open
၃.၄၄ US$
High
၃.၅၇ US$
Low
၃.၃၈ US$
Mkt. cap
၂၉.၃၁ ကုဋေ
Avg. vol.
၃.၅၂ သန်း
Volume
၁.၉၄ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၃.၀၅ US$
EPS
-၃.၇၄ US$
Beta
၁.၆၇
Shares outstanding
၈.၆၂ ကုဋေ
No. of employees
၂၁၄
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
Retension Pharmaceuticals, Clinical-Stage Developer of Hypertension Therapies, Files for Nasdaq Capital Market IPO
Quiver Quantitative
·
ပြီးခဲ့သည့် ၅၄ မိနစ်
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
The Manila Times
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
Seeking Alpha
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
Depreciation Subtleties: S&P Earnings Are Vastly Overstated (NYSEARCA:SPY)
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees၂၁၄
Founded၂၀၀၀
HeadquartersWatertown, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteeyepoint.bio